Stimuli-responsive platinum and ruthenium complexes for lung cancer therapy

• Päätekijät: Cheng Zhang (Tekijä), Tong Kang (Tekijä), Xinyi Wang (Tekijä), Jiaqi Song (Tekijä), Jia Zhang (Tekijä), Guanying Li (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Lung cancer is the most common cause of cancer-related deaths worldwide. More efficient treatments are desperately needed. For decades, the success of platinum-based anticancer drugs has promoted the exploration of metal-based agents. Four ruthenium-based complexes have also entered clinical trials...